|
Volumn 89, Issue 3, 2004, Pages 265-269
|
Malaria: Integrated approaches for prevention and treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,8 BIS(TRIFLUOROMETHYL) 4 (3 HYDROXYQUINUCLIDINYL)QUINOLINE;
ANTIMALARIAL AGENT;
ARTEMISININ DERIVATIVE;
ATOVAQUONE PLUS PROGUANIL;
CHLOROQUINE;
CHLORPHENOTANE;
CHLORPROGUANIL PLUS DAPSONE;
CHOLINE DERIVATIVE;
ENDOPEROXIDE;
FANSIDAR;
FOLIC ACID ANTAGONIST;
G 25;
GOLD;
HEMOGLOBIN;
INSECT REPELLENT;
MEFLOQUINE;
MERCURY;
MEROZOITE SURFACE PROTEIN 1;
NEW DRUG;
PROTEINASE;
QUINOLINE DERIVATIVE;
THIAMINE;
UNCLASSIFIED DRUG;
AIR CONDITIONING;
ANOPHELES;
BED NET;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG TARGETING;
EDITORIAL;
ELECTROPHORESIS;
ENVIRONMENTAL FACTOR;
HUMAN;
INFECTION CONTROL;
INFECTION PREVENTION;
INFECTION RISK;
INFECTION SENSITIVITY;
INSECT CONTROL;
MALARIA;
MALARIA CONTROL;
MALARIA FALCIPARUM;
MEDICAL RESEARCH;
MINING;
MORTALITY;
NONHUMAN;
NUTRITIONAL STATUS;
PARASITE IDENTIFICATION;
PARASITE TRANSMISSION;
PLASMODIUM;
PREGNANCY;
PROTECTIVE CLOTHING;
PROTEIN DEGRADATION;
THIAMINE DEFICIENCY;
TRAVEL;
WORLD HEALTH ORGANIZATION;
INSECTA;
|
EID: 1642565108
PISSN: 0001706X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.actatropica.2003.10.001 Document Type: Editorial |
Times cited : (9)
|
References (0)
|